期刊文献+

高频彩色多普勒超声和血清甲状腺球蛋白在分化型甲状腺癌^(131)I清除残余甲状腺后随访中的应用 被引量:6

Application of high-frequency Doppler ultrasonography and serum thyroglobulin in follow-up of differentiated thyroid cancer after (131)~I remnant ablation
下载PDF
导出
摘要 目的探讨高频彩色多普勒超声检查和血清甲状腺球蛋白(Tg)检测在分化型甲状腺癌(DTC)131I清除残余甲状腺后随访中的临床应用价值。方法回顾性分析92例接受甲状腺近全或全切除术联合131I清除残余甲状腺治疗的DTC患者资料。根据血清Tg水平分为血清Tg<2ng/ml组、2~10ng/ml组及>10ng/ml组,比较各组间DTC复发转移率的差异。以临床随访131I全身扫描或病理结果为金标准,评价高频彩色多普勒超声、血清Tg检测及二者联合应用诊断DTC复发转移的效能。结果 92例中,39例DTC复发转移。血清Tg<2ng/ml组、2~10ng/ml组及>10ng/ml组复发转移率分别为14.81%(8/54)、41.67%(5/12)及100%(26/26),组间差异有统计学意义(P<0.05)。高频彩色多普勒超声诊断DTC复发转移的敏感度、特异度、准确率、阳性预测值、阴性预测值分别为89.74%(35/39)、90.57%(48/53)、90.22%(83/92)、87.50%(35/40)、92.31%(48/52),血清Tg检测分别为79.49%(31/39)、86.79%(46/53)、83.70%(77/92)、81.58%(31/38)及85.19%(46/54),二者联合应用分别为94.87%(37/39)、86.79%(46/53)、90.22%(83/92)、84.09%(37/44)、95.83%(46/48)。结论高频彩色多普勒超声检查和血清Tg检测均可用于DTC患者131I清除残余甲状腺后的随访,二者联合应用有利于及早发现复发转移。 Objective To investigate the application value of high-frequency Doppler ultrasonography and detection of serum thyroglobulin(Tg)in the follow-up of differentiated thyroid cancer(DTC)after 131 I remnant ablation.Methods A retrospective analysis of 92 patients underwent near-total or total thyroidectomy and 131 I remnant ablation was performed.The patients were divided into 3 groups according to serum Tg concentrations,included serum Tg〈2ng/ml,2—10ng/ml and10ng/ml groups.The ratios of recurrence metastasis were compared among 3 groups.The diagnostic efficiencies of high-frequency Doppler ultrasonography,serum Tg detection and the combination of two methods were evaluated,taking the results of 131I-whole body scan or pathology during follow-up as the gold standard.Results There were 39 of 92patients of recurrence metastasis.The ratios of recurrence metastasis was 14.81%(8/54)in serum Tg〈2ng/ml group,41.67%(5/12)in serum Tg 2—10ng/ml group and 100%(26/26)in serum Tg〉10ng/ml group,respectively.There was statistical difference among 3groups(P〈0.05).The sensitivity,specificity,accuracy,positive predictive value and negative predictive value in the diagnosis of DTC recurrence metastasis was 89.74%(35/39),90.57%(48/53),90.22%(83/92),87.50%(35/40)and 92.31%(48/52)of high-frequency Doppler ultrasonography,79.49%(31/39),86.79%(46/53),83.70%(77/92)81.58%(31/38)and 85.19%(46/54)of serum Tg detection,94.87%(37/39),86.79%(46/53),90.22%(83/92),84.09%(37/44)and 95.83%(46/48)of two methods combination,respectively.Conclusion The high-frequency Doppler ultrasonography and serum Tg detection are valuable for the follow-up of DTC patients after 131 I remnant ablation.The combination of two methods is helpful to detect the recurrence metastasis in early.
出处 《中国介入影像与治疗学》 CSCD 北大核心 2015年第10期621-624,共4页 Chinese Journal of Interventional Imaging and Therapy
关键词 甲状腺肿瘤 分化型 超声检查 多普勒 彩色 高频 血清甲状腺球蛋白 Thyroid neoplasms Differentiated Ultrasonography Doppler color High-frequency Serum thyroglobulin
  • 相关文献

参考文献11

二级参考文献62

  • 1胡莹莹,蒋宁一.^(131)Ⅰ治疗分化型甲状腺癌的现状和进展[J].国际放射医学核医学杂志,2006,30(6):343-346. 被引量:11
  • 2Mazzaferri EL, Robbins R J, Spencer CA, et al. A consensus report of the role of serum thyroglobublin as a monitoring method for low-risk patientswithpapillarythyroidcarcinoma [J]. JClinEndocrinol Meta, 2003, 88(4): 1433-1441.
  • 3Pacini F, Fugazzola L, Lippi F, et al. Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer [J]. J Clin Endocrinol Metab, 1992, 74(6): 1401-1404.
  • 4Spencer CA, Wang C, Fatemi S, et al. Serum thyroglobulin autoanti bodies: Prevalence, influence on serum thyroglobulin measurement and prognostic significance in patients with differentiated thyroid carcinoma[J]. J Clin Endocrinol Metab, 1998, 83(4): 1121
  • 5Massart C, Maugendre D. Importance of the detection method for thyroglobulin antibodies for the validity of thyroglobulin measurements in sera from patients with Graves' disease[J]. Clin Chem, 2002,48(1): 102-107.
  • 6Girelli ME, De Vido D. Serum thyroglobulin measurements in differentiated thyroid cancer[J]. Biomed Pharmacother, 2000, 54(6): 330-333.
  • 7Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyroglobulin assays[J]. Clin Chem, 1996, 42(1): 164-173.
  • 8Hjiyiannakis P, Mundy J, Harmer C. Thyroglobulin antibodies in differentiated thyroid cancer[J]. Clin Oncol, 1999, 11(4): 240-244.
  • 9SCHLUMBERGER M.Follow-up of Patients With Differentiated Thyroid Cancer[C]// Johnson JT,Didolkar MS.Head and Neck Cancer.Amsterdam:Elsevier Science Publishers,1993:903.
  • 10HARMER CL.Thyroid Cancer[C]// Oncology HA.A Multidisciplinary Textbook.London:Chapman and Hall,1995:565-584.

共引文献70

同被引文献47

引证文献6

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部